On September 12th Governor Tom Wolf (D) participated in the ribbon cutting at Harmony Biosciences new headquarters in Plymouth Meeting. The 15,651 square foot headquarters is located at 630 W. Germantown Pike. Harmony Biosciences will initially employ 42 staff members at the headquarters and has plans to significantly expand its workforce over the coming years. Harmony Biosciences is a private biopharmaceutical company dedicated to developing and commercializing novel treatment options for people living with rare diseases. Pictured above (left to right) are Chris Molineaux, President and CEO of Life Sciences PA, Governor Wolf and John C. Jacobs, President and CEO of Harmony Biosciences.
“At Harmony, we take seriously our responsibilities and commitments to those who live with rare diseases, our employees, business partners and the broader life sciences community in our headquarters state of Pennsylvania,” said John C. Jacobs, President and CEO. “We were deeply honored that Governor Wolf participated in today’s ribbon cutting for our new facility, which speaks to his ongoing support of economic development, jobs creation and the growth of innovative, emerging companies in the biopharmaceutical hub of Philadelphia.”
“From our founding, Pennsylvania and Pennsylvania-based companies have always been trail blazers in the life sciences,” said Governor Tom Wolf. “We as a commonwealth are proud to be the home of so many of the important leaders shaping the healthcare and life sciences industry today. I want to thank Harmony Biosciences for choosing Pennsylvania as the best place to do such important and life-changing work.”
Harmony previously received Life Sciences Pennsylvania’s 2017 Deal of the Year award recognizing the company’s efforts in raising the largest private equity investment in the biotech industry in Pennsylvania. The company is currently focusing on the registration and commercialization of its investigational product for the treatment of narcolepsy.
Photo: Harmony Biosciences